首页> 外文期刊>Clinical proteomics. >Mass spectrometry-based microbiological testing for blood stream infection
【24h】

Mass spectrometry-based microbiological testing for blood stream infection

机译:基于质谱的血流感染微生物学检测

获取原文
       

摘要

The most successful application of mass spectrometry (MS) in laboratory medicine is identification (ID) of microorganisms using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) in blood stream infection. We describe MALDI-TOF MS-based bacterial ID with particular emphasis on the methods so far developed to directly identify microorganisms from positive blood culture bottles with MALDI-TOF MS including our own protocols. We touch upon the increasing roles of Liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) as well. Because blood culture bottles contain a variety of nonbacterial proteins that may interfere with analysis and interpretation, appropriate pretreatments are prerequisites for successful ID. Pretreatments include purification of bacterial pellets and short-term subcultures to form microcolonies prior to MALDI-TOF MS analysis. Three commercial protocols are currently available: the Sepsityper? kit (Bruker Daltonics), the Vitek MS blood culture kit (bioMerieux, Inc.), and the rapid BACpro? II kit (Nittobo Medical Co., Tokyo). Because these commercially available kits are costly and bacterial ID rates using these kits are not satisfactory, particularly for Gram-positive bacteria, various home-brew protocols have been developed: 1. Stepwise differential sedimentation of blood cells and microorganisms, 2. Combination of centrifugation and lysis procedures, 3. Lysis-vacuum filtration, and 4. Centrifugation and membrane filtration technique (CMFT). We prospectively evaluated the performance of this CMFT protocol compared with that of Sepsityper? using 170 monomicrobial positive blood cultures. Although preliminary, the performance of the CMFT was significantly better than that of Sepsityper?, particularly for Gram-positive isolates. MALDI-TOF MS-based testing of polymicrobial blood specimens, however, is still challenging. Also, its contribution to assessment of susceptibility and resistance to antibiotics is still limited. For this purpose, liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) should be more useful because this approach can identify as many as several thousand peptide sequences. MALDI-TOF MS is now an essential tool for rapid bacterial ID of pathogens that cause blood stream infection. For the purpose of assessment of susceptibility and resistance to antibiotics of the pathogens, the roles of liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) will increase in the future.
机译:在实验室药物中最成功的质谱(MS)在实验室药物中的鉴定(ID)使用基质辅助激光解吸电离 - 在血流感染中的飞行质谱(MALDI-TOF MS)的基质辅助激光解吸电离 - 时间。我们描述了MALDI-TOF基于MS的细菌ID,特别强调到目前为止发达的方法,以直接识别来自阳性血液培养瓶的微生物,MALDI-TOF MS包括我们自己的协议。我们也触及液相色谱(LC)耦合的型致串联质谱(MS / MS)的作用。由于血液培养瓶含有各种可能干扰分析和解释的非细菌蛋白质,所以适当的预处理是成功ID的先决条件。预处理包括纯化细菌颗粒和短期亚脱培养,以在MALDI-TOF MS分析之前形成微菌根。目前有三项商业协议:Sepsityper?套件(Bruker Daltonics),Vitek MS血液文化套件(BioMerieux,Inc。),以及快速的Bacpro? II套件(Nittobo Medical Co.,东京)。由于这些市售试剂盒是昂贵的,并且使用这些试剂盒的细菌ID速率不令人满意,特别是对于革兰氏阳性细菌,已经开发了各种自制的自制方案:1。培养的血细胞和微生物的逐步差异沉降,2.离心组合和裂解程序,3.裂解 - 真空过滤,4.离心和膜过滤技术(CMFT)。我们预期评估了该CMFT协议的性能与Sepsiteper相比?使用170个单眼的阳性血液培养物。虽然初步,CMFT的性能明显优于Sepsityper的性能,特别是对于革兰氏阳性分离物。然而,MARDI-TOF MS的多发性血液标本测试仍然具有挑战性。此外,它对评估易感性和对抗生素抗性评估的贡献仍然有限。为此目的,液相色谱(LC)与串联质谱(MS / MS)偶联应更有用,因为这种方法可以鉴定多达数千份肽序列。 MALDI-TOF MS现在是导致血流感染的病原体的快速细菌ID的重要工具。为了评估易感性和抗生素的抗生素的抗生素,液相色谱(LC)与串联质谱(MS / MS)的作用将来会增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号